Hiring data keeps coming in strong ahead of Friday's jobs report — position in banks to profit from more Fed hikes

Verdict: Banks-plus-hot-jobs thesis is coherent, but BAC's weak quarter and unconfirmed entries say wait

Our stance is wait, with a near-dated horizon: the rate-hike repricing story is live around Friday's jobs report, but the entry conditions are not confirmed and no robust strategy setup was established because the backtest could not be run (raw and adjusted price series for BAC, JPM and KBE used different bases). The strongest support is JPM: Q2 2026 net income rose 28.3% sequentially to $21.2B with return on equity up to 5.65%, and both banks keep shrinking share counts and growing dividends (BAC's payout up about 9.4% a year). The strongest objection is BAC's most recent reported quarter — net income down 23.6% to $6.93B, margin down 5.6 points to 23.1%, and operating cash flow swinging to negative $6.5B — plus provisional insider filings through September 30, 2026 showing net open-market selling at both banks. KBE's momentum screen is close (price $67.42, above the $66.01 50-day EMA, RSI at 67.0, MACD positive) but the Donchian breakout above $65.41 is not confirmed, and BAC and JPM sit below their own 50-day EMAs, so the sector has not validated itself. A hot jobs print alongside confirmed breakouts and BAC margin recovery would flip us to buy; a soft print that drags KBE below its 50-day EMA kills the idea outright.

Trade now: the bank trade needs its breakout trigger, not just a good story

The business thesis is coherent and currently unfalsified: the idea argues that hot labor data pushes the Fed toward more hikes, and banks that lend at floating rates — BAC and JPM — are a clean way to play that repricing, with the sector left under-owned after the midterm-driven rotation into bonds. But the thesis being attractive is not the same as today's entry conditions being met, so the answer is: wait for a named price trigger before acting. Concretely, the strategy is a long setup on KBE (the bank ETF), entered when KBE's daily close crosses above its 20-day Donchian channel top, with price above the 50-day EMA, the 14-day RSI above 50, and the MACD line above its signal line. As of the November 4, 2026 observation, three of those four conditions are already met on KBE: the close sits at $67.42, above the 50-day EMA of $66.01; RSI reads 67.0; and MACD is positive. The remaining condition — a confirmed Donchian breakout above $65.41 — is close but unconfirmed. "Waiting" means letting KBE print that confirmed breakout on the daily chart rather than buying on the story alone. Scope note: the historical performance of this exact rule set was not measured — the backtest failed because raw and adjusted price series for BAC, JPM, and KBE used different bases — so we are evaluating a thesis plus live conditions, not a measured track record. No robust parameter setup was established either; the frozen rules stand as published. The downside that matters: if the jobs data lands soft and the rate-hike repricing reverses, the strategy's own exits handle it — a hard stop at a 2% unrealized loss, a sector invalidation exit if KBE closes below its 50-day EMA, and a trailing exit once profitable if price slips below the 20-day EMA. KBE is currently $1.41 above that 20-day EMA, so the cushion is thin from here. ### Technical details **Entry (long, all four conditions required, KBE daily chart, observed 2026-11-04 15:52 UTC, last close $67.42):** - Donchian (20) breakout: close must cross above $65.41. Current price is $2.01 above the level, but the cross itself is flagged as near rather than confirmed — a close above the channel top on the daily bar is the trigger. - Price above 50-day EMA ($66.01): met, price is $1.41 above. - RSI (14) above 50: met at 67.0. RSI is a 0–100 momentum gauge; readings above 50 indicate stronger recent buying than selling. - MACD (12,26,9) line above its signal line: met, with MACD at +0.36. MACD compares short- and long-term moving averages; a positive gap signals upward momentum. **Exits (all live rules):** - Hard stop: exit if unrealized loss reaches 2.0%. - Sector invalidation: exit if KBE closes below its 50-day EMA, currently $66.01. - Trailing exit: once profitable, exit if close falls below the 20-day EMA, currently $65.67. - Take-profit levels: exit at a 4.0% unrealized gain, or on reaching the second-ranked resistance level, currently around $68.27 on KBE. - Time stop: exit after 90 trading bars (about four and a half months). **Position sizing per the rule set:** fixed-risk method with a 2% risk budget, support-stop rank 2, maximum 33.3% of the book per position, minimum position value $100. **Cross-checks:** JPM closed at $337.9, just below its 50-day EMA of $339.8, and BAC closed at $51.06, about $3.32 below its 50-day EMA of $54.38 — so the two named banks have not confirmed the trend strength that KBE already shows. The idea's TLT leg (long Treasuries as the bearish counterpart) is consistent with TLT trading above its 50-day EMA at $81.34.

Earnings power and dividend growth give the rate-hike trade a fundamental floor

Takeaway: the bull case rests on two pillars — the macro catalyst described in the idea (hot jobs data forcing markets to price more Fed hikes, per the MarketWatch piece on the Friday jobs report) and, more concretely, the supplied fundamentals showing genuine earnings and payout growth at both JPMorgan Chase (JPM) and Bank of America (BAC). ### JPM is firing on earnings, margins and buybacks JPM's Q2 2026 net income came in at $21.2B, up 28.3% from $16.5B in Q1, and its return on equity (profit earned per dollar of shareholder capital) rose from 4.53% to 5.65%. Shares outstanding fell from 2.68B to 2.66B, meaning buybacks are shrinking the share count and compounding per-share earnings. If the 'more hikes' repricing plays out, this is the franchise best positioned to translate it into net interest income without needing anything else to go right. ### BAC shows year-over-year revenue and payout growth BAC's Q3 2026 revenue of $30.0B is up roughly 3.2% from $29.0B a year earlier, and full-year 2025 revenue reached $113.1B versus $105.9B in 2024 — steady top-line expansion. Shares outstanding have been cut every quarter, from 7.63B in early 2024 to 6.92B in Q3 2026. The dividend has grown about 9.4% per year, with the trailing twelve-month payout now $1.16 per share versus $1.06 over the prior twelve months — a shareholder-return cushion while the rate thesis plays out. ### The catalyst is near-dated and sector-wide The idea's trigger is observable and soon: Reuters reported job openings jumped sharply in September, ADP reported 86,000 private jobs added in October, and per the MarketWatch piece…

Scores

• Conviction score breakdown: 51
• Thesis support: 60
• Trade readiness: 45
• Risk quality: 50
• Fundamentals trend: 48

Watch items

• KBE — 20-day Donchian upper channel
• KBE — 50-day EMA
• BAC — 50-day EMA
• JPM — 50-day EMA
• TLT — 50-day EMA